Novel Hydrogel Material As a Potential Embolic Agent in Embolization Treatments

Feng Zhou,Liming Chen,Qingzhu An,Liang Chen,Ying Wen,Fang,Wei Zhu,Tao Yi
DOI: https://doi.org/10.1038/srep32145
IF: 4.6
2016-01-01
Scientific Reports
Abstract:We report a novel graphene-oxide (GO) enhanced polymer hydrogel (GPH) as a promising embolic agent capable of treating cerebrovascular diseases and malignant tumors, using the trans-catheter arterial embolization (TAE) technique. Simply composed of GO and generation five poly(amidoamine) dendrimers (PAMAM-5), our rheology experiments reveal that GPH exhibits satisfactory mechanical strength, which resist the high pressures of blood flow. Subcutaneous experiments on Sprague-Dawley (SD) rats demonstrate the qualified biocompatibility of GPH. Finally, our in vivo experiments on New Zealand rabbits, which mix GPH with the X-ray absorbing contrast agent, Iohexol, reveal complete embolization of the artery. We also note that GPH shortens embolization time and exhibits low toxicity in follow-up experiments. Altogether, our study demonstrates that GPH has many advantages over the currently used embolic agents and has potential applications in clinical practice.
What problem does this paper attempt to address?